Inozyme Pharma (NASDAQ:INZY) reported its Q4 earnings results on Tuesday, March 12, 2024 at 08:30 AM.

Here's what investors need to know about the announcement.

Earnings

Inozyme Pharma missed estimated earnings by -3.0%, reporting an EPS of $-0.33 versus an estimate of $-0.32.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 3.0% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Inozyme Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.